BIODLINK-B

1875
3.4702.36% ( +0.080 )
Delay Closed: Nov 16, 16:08:00

Overview

BIODLINK-B (1875)

BioDlink International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in...

Open
3.370
High
3.485
Low
3.340
Prev. Close
3.390
Volume
780.00K
Turnover
2.65M
Avg Price
3.393
Bid/Ask Ratio
-92.86%
Amplitude
4.28%
52wk High
5.870
Volume Ratio
1.84
Turnover Ratio
0.10%
52wk Low
1.700
HK Mkt Cap
2.68B
Market CapHKD
2.68B
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-0.243
EPSDynamic
-0.174
EPSStatic
--
BVPS
0.92
P/B
3.79
HK Shares
772.79M
Dividend YieldTTM
--
DividendTTM
--
Shares
772.79M
Min lot size
400
Currency
HKD

BIODLINK-B Analyst Rating

View more

Forecast & Rating

Jun 5, 2026
Price forecast
HK$4.4026.75%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    TOT Biopharm closed up 3.45% at HKD 3.60, opening higher and touching HKD 3.71 during the morning session before retreating to a low of HKD 3.58 in the afternoon, driven by progress in parent WuXi XDC's premium takeover offer. EPS remained negative for two straight quarters with loss widening over 30x YoY, as Q4 revenue tumbled 53% to HKD 144 million and net loss expanded to HKD 58 million, while the stock still trades 38.67% below its 52-week high of HKD 5.87 yet above its 20-day MA of HKD 3.41, with YTD decline of 14%.

News